Does Dr. JESSICA BAILEY DEBLOIS have financial conflicts of interest?

Dr. JESSICA BAILEY DEBLOIS (APRN, FNP-C) has received a total of $6,049 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $6,049 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JESSICA BAILEY DEBLOIS?

According to CMS Open Payments data, Dr. JESSICA BAILEY DEBLOIS received funding from ABBVIE ($3,417), TEVA PHARMACEUTICALS USA ($478), and PFIZER ($431).

Does Dr. JESSICA BAILEY DEBLOIS receive research grants or speaking fees?

Dr. JESSICA BAILEY DEBLOIS has received $6,049 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JESSICA BAILEY DEBLOIS

APRN, FNP-CReal-Time Hydrated

Specialty: Nurse Practitioner, Family

Practice Location: NASHVILLE, TN 37232

NPI Number: 1730768185

LIFETIME INDUSTRY VALUE

$6,049

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BAILEY DEBLOIS is a verified Nurse Practitioner, Family practitioner based in NASHVILLE, TN.

Between 2021 and 2025, Dr. BAILEY DEBLOIS had an overall industry promotional and research financial footprint of $6,049 as recorded in the federal CMS Open Payments database.

$6,049 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BAILEY DEBLOIS's primary funding source is ABBVIE, which accounts for $3,417 (representing 56.5% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBVIE

Rank 1

$3,417

56.5%

TEVA PHARMACEUTICALS USA

Rank 2

$478

7.9%

PFIZER

Rank 3

$431

7.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.